# FDA recall D-0129-2018

> **Premier Pharmacy Labs Inc** · Class II · drug recall initiated 2017-08-10.

## Product

Neostigmine Methylsulfate (single dose syringe) 1 mg per mL 5 mg per 5 mL Injectable Hospital/Office Use Only Compounded by: Premier Pharmacy Labs., Inc. 8265 Commercial Way Weeki Wachee, FL 34613,  NDC# 69623-234-15

## Reason for recall

Stability Date Doesn't Support Expiry: labeling error indicating a beyond use date that exceeds current stability data.

## Distribution

Michigan, Maryland, Minnesota, North Carolina, Ohio, Florida

## Key facts

- **Recall number:** D-0129-2018
- **Recalling firm:** Premier Pharmacy Labs Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-08-10
- **Report date:** 2017-12-27
- **Termination date:** 2018-03-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Weeki Wachee, FL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0129-2018

## Citation

> AI Analytics. FDA recall D-0129-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0129-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*